ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
AzurRx BioPharma Inc

AzurRx BioPharma Inc (AZRX)

3.45
0.00
(0.00%)
終値: 1月7日 6:00AM
3.45
0.00
( 0.00% )
取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
3.45
買値
3.41
売値
3.51
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
3.45
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
13,500,000
配当利回り
-
PER
-2.48
1 株当たり利益 (EPS)
-1.19
歳入
-
純利益
-16.1M

AzurRx BioPharma Inc について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-

AZRX 最新ニュース

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI” Three IBD clinical indications, including ulcerative colitis and Crohn’s disease, added to...

AzurRx BioPharma Announces Reverse Stock Split

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the...

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of RESERVOIR Trial to Enroll Up to 150 Patients to Evaluate Efficacy of FW-1022...

AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AZRX - Frequently Asked Questions (FAQ)

What is the current AzurRx BioPharma share price?
The current share price of AzurRx BioPharma is US$ 3.45
How many AzurRx BioPharma shares are in issue?
AzurRx BioPharma has 13,500,000 shares in issue
What is the market cap of AzurRx BioPharma?
The market capitalisation of AzurRx BioPharma is USD 46.58M
What is the 1 year trading range for AzurRx BioPharma share price?
AzurRx BioPharma has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of AzurRx BioPharma?
The price to earnings ratio of AzurRx BioPharma is -2.48
What is the reporting currency for AzurRx BioPharma?
AzurRx BioPharma reports financial results in USD
What is the latest annual profit for AzurRx BioPharma?
The latest annual profit of AzurRx BioPharma is USD -16.1M
What is the registered address of AzurRx BioPharma?
The registered address for AzurRx BioPharma is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the AzurRx BioPharma website address?
The website address for AzurRx BioPharma is www.enterothera.com
Which industry sector does AzurRx BioPharma operate in?
AzurRx BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MSAIMultiSensor AI Holdings Inc
US$ 2.85
(42.50%)
2.56M
MCVTMill City Ventures III Ltd
US$ 3.04
(34.51%)
101.81k
XTIAXTI Aerospace Inc
US$ 0.1168
(32.73%)
377.71M
CDTConduit Pharmaceuticals Inc
US$ 0.0938
(29.74%)
17.08M
QRTEBQurate Retail Inc
US$ 3.13
(22.27%)
103
ENVBEnveric Biosciences Inc
US$ 0.3388
(-19.81%)
480.17k
AMSTAmesite Inc
US$ 3.45
(-14.81%)
60.67k
WATTEnergous Corporation
US$ 1.05
(-14.63%)
631.72k
SLRNACELYRIN Inc
US$ 2.9799
(-14.62%)
506.19k
ACXPAcurx Pharmaceuticals Inc
US$ 0.9401
(-13.75%)
166.52k
XTIAXTI Aerospace Inc
US$ 0.1168
(32.73%)
377.71M
SVMHSRIVARU Holding Ltd
US$ 0.0516
(11.45%)
30.11M
CRKNCrown Electrokinetics Corporation
US$ 0.1428
(7.37%)
29.76M
CEROCERo Therapeutics Holdings Inc
US$ 0.0468
(10.64%)
19.12M
CDTConduit Pharmaceuticals Inc
US$ 0.0938
(29.74%)
17.08M

最近閲覧した銘柄

Delayed Upgrade Clock